Renal outcomes of treatment with telmisartan in patients with stage 3-4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA).

Mineaki Kitamura,Hideyuki Arai,Shinichi Abe,Yuki Ota,Kumiko Muta,Akira Furusu,Hiroshi Mukae,Shigeru Kohno,Tomoya Nishino

Renal outcomes of treatment with telmisartan in patients with stage 3-4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA).

2020

Mineaki Kitamura
Hideyuki Arai
Shinichi Abe
Yuki Ota
Kumiko Muta
Akira Furusu
Hiroshi Mukae
Shigeru Kohno
Tomoya Nishino

Objectives:Although angiotensin II receptor blockers are effective for patients with chronic kidney disease, dose-dependent renoprotective effects of angiotensin II receptor blockers in patients wi...

Keywords:

Kidney disease
Proteinuria
Medicine
Urology
Telmisartan
Randomized controlled trial
Angiotensin II Receptor Blockers
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations